Del Mar Pharmaceuticals was recently added to the roster of presenting companies at OneMedForum NY 2011.
Global Cancer Consortium
Aduro Biotech, OneMedForum SF Presenting Company, Announces $20 Million Financing
Aduro BioTech, a OneMedForum presenting company is engineering Listeria to treat Pancreatic Cancer and other infectious diseases.
New Software From iCAD Helps Doctors Diagnose Prostate Cancer
New software being used at Englewood Hospital and Medical Center should help detect prostate cancer earlier, eliminate unnecessary testing procedures and help form a treatment plan.
VisEn Medical Develops New Light Based Diagnostics
Technology that enables the fast and sensitive detection of biological and disease specific markers in live tissue is a major need in the diagnostic field. VisEn Medical has developed a breakthrough proprietary […]
OneMedForum NY 2011 Grows Its Advisory Board And Selects Initial Presenters
OneMedForum NY 2011, to be held June 23 -24, has added new members to the Advisory Board and selected an initial group of “discovery” lesser known companies with terrific growth potential.
Receptor Logic Develops Improved Diagnostic Antibodies
Antibody based diagnostics and therapeutics represent a major medical advance as they respectively identify diseases with high specificity and preclude systemic side effects by recognizing diseased tissue only, yet an important drawback […]
PlexPress Develops Large Scale Genetic Analysis
The streamlining of advanced molecular diagnostics, particularly in genetics, is essential for expanding the use of the most cutting-edge technology throughout the healthcare industry. PlexPress s a biopharmaceutical company that has developed […]
EDP Biotech Detects Early Stage Colon Cancer
Identification and detection of new biomarkers that identify the beginning stages of diseases is critical for achieving successful medical treatment. EDP Biotech Corporation is a medical device company that is developing a […]
